Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3273853
Max Phase: Preclinical
Molecular Formula: C27H28Cl2N8O5
Molecular Weight: 615.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3273853
Max Phase: Preclinical
Molecular Formula: C27H28Cl2N8O5
Molecular Weight: 615.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(CC1=Nc2c(N)nc(N)nc2N(Cc2ccc(Cl)c(Cl)c2)C1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
Standard InChI: InChI=1S/C27H28Cl2N8O5/c1-36(17-5-3-15(4-6-17)25(40)33-20(26(41)42)8-9-21(38)39)12-16-13-37(11-14-2-7-18(28)19(29)10-14)24-22(32-16)23(30)34-27(31)35-24/h2-7,10,20H,8-9,11-13H2,1H3,(H,33,40)(H,38,39)(H,41,42)(H4,30,31,34,35)/t20-/m0/s1
Standard InChI Key: DOUGGQRTFUJRNA-FQEVSTJZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 615.48 | Molecular Weight (Monoisotopic): 614.1560 | AlogP: 3.22 | #Rotatable Bonds: 11 |
Polar Surface Area: 200.36 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.25 | CX Basic pKa: 6.82 | CX LogP: 1.62 | CX LogD: -2.05 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.21 | Np Likeness Score: -0.84 |
1. Chaykovsky M, Hirst M, Lazarus H, Martinelli JE.. (1977) Methotrexate analogues. 9. Synthesis and biological properties of some 8-alkyl-7,8-dihydro analogues., 20 (10): [PMID:409842] [10.1021/jm00220a019] |
Source(1):